SciELO - Scientific Electronic Library Online

 
vol.66 número3An updated and global review on prostate cancerBasophil activation test: technical aspects, methodology and clinical utility índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista de la Facultad de Medicina

versão impressa ISSN 0120-0011

Resumo

RINCON-ALVAREZ, Óscar Javier  e  NEIRA-TORRES, Liliana Isabel. Hearing loss and rheumatoid arthritis, systemic lupus erythematosus and Sjögren 's syndrome. rev.fac.med. [online]. 2018, vol.66, n.3, pp.439-446. ISSN 0120-0011.  https://doi.org/10.15446/revfacmed.v66n3.60636.

Introduction:

Currently, figures on people suffering from rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or Sjögren's syndrome (SS) are not available, as well as information on auditory alterations caused by the pharmacological treatment used to control said diseases.

Objective:

To demonstrate possible hearing and vestibular disorders caused by RA, SLE and SS or their pharmacological treatment.

Materials and methods:

Clinical findings of diagnostic tools and prevention and intervention procedures for hearing disorders found in research articles published in Spanish, English, French and Portuguese in scientific databases between 2000 and 2016 were analyzed.

Results:

62 research papers were obtained (31 on RA, 5 on SLE, 12 on SS, 5 on immune-mediated hearing loss, and 9 on ototoxic drugs), a doctoral thesis on RA, a doctoral thesis on RA and LES and a clinical practice guideline for the early detection, diagnosis and treatment of RA. The most frequent types of hearing loss reported are sensorineural hearing loss, ossicular chain lesions and vestibular-cochlear disorders.

Conclusions:

The relationship between hearing lesions and RA, LES and SS was confirmed, but the development of ototoxic drugs is not clear yet.

Palavras-chave : Autoimmune Diseases; Rheumatoid Arthritis; Systemic Lupus Erythematosus; Antimalarials (MeSH).

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )